Tempus AI Projects 2026 Revenue Between $1.60B and $1.605B with Target Adjusted EBITDA of $65M
Tempus AI (TEM) reported strong third-quarter performance, driven by broad-based growth across its Diagnostics and Data & Applications business segments. CEO Eric Lefkofsky highlighted the company's momentum as it continues to scale its integrated healthcare data platform. Looking ahead, the company provided long-term financial guidance, projecting 2026 revenue in the range of $1.60 billion to $1.605 billion. Tempus also aims to achieve an adjusted EBITDA of approximately $65 million by 2026, supported by strategic collaborations such as its partnership with Bristol Myers Squibb (BMS).
Tickers: $TEM
Topics: data and applications diagnostics earnings report revenue growth
Read the full article at Seeking Alpha
Part of the story Kelly Services Projects Q4 Adjusted EBITDA Margin Between 3.8% and 4% (21 articles)